C16.2
Malignant neoplasm of body of stomach
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the body of the stomach, classified under ICD-10 code C16.2, refers to a type of stomach cancer that originates in the main part of the stomach, known as the body. This region of the stomach is central to the digestive process, and cancer here can significantly affect nutritional intake and overall health. Recognizing the nature of this disease, the risk factors, symptoms, and treatment options can help inform affected individuals and their families about potential management strategies.
Causes & Symptoms
Clinical Causes: Genetic predisposition and family history of stomach cancer Helicobacter pylori (H. pylori) bacterial infection, which can cause chronic inflammation Diet high in smoked, salted, or pickled foods Tobacco use and smoking Excessive alcohol consumption Chronic stomach conditions such as gastritis or pernicious anemia Previously undergone stomach surgery Exposure to certain environmental toxins or carcinogens Age, with a higher risk in older adults Poor overall diet and nutritional deficiencies
Key Symptoms: Persistent indigestion or heartburn Unintentional weight loss Feeling full after small meals Nausea or vomiting, sometimes with blood Abdominal pain or discomfort in the upper stomach area Swelling or a mass in the abdomen Difficulty swallowing if the tumor blocks the passage Fatigue and weakness due to anemia or general debilitation Loss of appetite
Diagnostic & Treatment
Diagnosis Path: The diagnosis of malignant neoplasm of the stomach's body typically involves a combination of methods: - Endoscopy: A flexible tube with a camera to examine the stomach lining and obtain tissue samples for biopsy. - Biopsy: Laboratory analysis of tissue samples to confirm cancer and determine its characteristics. - Imaging tests: CT scans, PET scans, or ultrasound to assess the extent of the disease and check for metastasis. - Blood tests: To evaluate overall health, detect anemia, or identify tumor markers. Proper staging through these diagnostic tools is essential for planning effective treatment strategies.
Treatment Protocols: Managing malignant neoplasm of the stomach generally involves a multidisciplinary approach, often including: - Surgery: Partial or total gastrectomy to remove the tumor and affected tissue. - Chemotherapy: Use of drugs to kill cancer cells and reduce tumor size, often used before or after surgery. - Radiation therapy: Targeted radiation to destroy remaining cancer cells, usually in conjunction with other treatments. - Targeted therapy: Medications designed to target specific molecules involved in tumor growth. - Palliative care: Focused on relieving symptoms and improving quality of life when curative treatment isn’t possible. Treatment plans are tailored based on the stage of the cancer, the patient’s overall health, and other individual factors.
Clinical Advice & FAQs
Billing Guidance
Is C16.2 a billable ICD-10 code?
Yes, C16.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C16.2?
Clinical documentation must specify the nature of Malignant neoplasm of body of stomach and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
